PRICE T ROWE ASSOCIATES INC /MD/ - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 62 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q4 2021$17,000
-55.3%
15,2000.0%0.00%
Q3 2021$38,000
-15.6%
15,2000.0%0.00%
Q2 2021$45,000
-71.5%
15,200
-66.3%
0.00%
Q1 2021$158,000
-13.7%
45,124
+16.9%
0.00%
Q4 2020$183,000
-34.9%
38,603
-33.3%
0.00%
Q3 2020$281,00057,9030.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,030,533$22,539,0004.01%
ARS Investment Partners, LLC 796,367$8,840,0001.41%
Gagnon Advisors, LLC 194,579$2,160,0001.37%
GAGNON SECURITIES LLC 263,894$2,929,0000.84%
Benchmark Capital Advisors 96,235$1,068,0000.81%
PERKINS CAPITAL MANAGEMENT INC 94,550$1,050,0000.75%
Cortina Asset Management, LLC 645,718$7,167,0000.34%
EAM Investors, LLC 73,327$814,0000.13%
Whitegate Investment Counselors, Inc. 11,000$122,0000.02%
ROYCE & ASSOCIATES LP 299,353$3,323,0000.02%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders